Stocks · News reference
Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.09) by 300 percent. This is a 79.19 percent increase over losses of $(1.73) per share from
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Prothena Corp (NASDAQ:PRTA) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $(0.09) by 500 percent. This is a 120.81 percent increase over losses of $(1.73) per share from the
Read original at benzingaCrown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results and raising its FY26 EPS guidance. Other gaining stocks include SLGB, HIHO, WNW, CHNR, RDGT, ULBI, GLMD, SMTK, and PRTA while LBGJ is down 45.1%.
Read original at benzingaThe transthyretin amyloidosis treatment market is projected to grow from USD 8.95 billion in 2025 to USD 35.10 billion by 2035 at a 14.64% CAGR. Growth is driven by increased ATTR-CM diagnosis rates, FDA approvals of gene-silencing therapies like vutrisiran and acoramidis, improved diagnostic imaging, and expanding pipeline therapies. North America dominates with 46% market share, while Asia Pacific is the fastest-growing region.
Read original at globenewswire-inc